A clinical trial to study effect of Ashwagandharishta and polybion syrup in early presbyacusis.

Phase 3

Not yet recruiting

• Conditions: Unspecified sensorineural hearingloss. Ayurveda Condition: KARNAROGAH,

• Registration Number: CTRI/2023/02/050141
• Lead Sponsor: Tilak Ayurveda Mahavidyalaya

Brief Summary

The study will be intervened by the treatment of ashwagandharishta and polybion syrup to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective criteria for statistical analysis. Scoring will be designed according to improvement in speech discrimination score. The speech discrimination score will be calculated before treatment, during treatment and after treatment. The effect of treatment results will be assessed in regard to improvement in speech discrimination score.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-02-21
• Study Start: 2023-02-28

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

• Patients having presbyacusis.
• Patients ready to give consent.

Exclusion Criteria

• Patients having history of immunosuppresant disorder.
• patients having perforated tympanic membrane.
• Patients having hearing aid.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sample size 44 improvement in speech discrimination score	3 months

Secondary Outcome Measures

Name	Time	Method
Sample size 44 improvement in speech discrimination score	6 months

Trial Locations

Locations (1)

Seth Tarachand Ramnath Ayurvedic Hospital Pune; 🇮🇳 Pune, MAHARASHTRA, India

Seth Tarachand Ramnath Ayurvedic Hospital Pune

🇮🇳Pune, MAHARASHTRA, India

Dr Kiran Kannade

Principal investigator

9822064368

kirankannade@gmail.com